Is a buy-out imminent? Omnipodd technology is far superb than the rest of pumps on market. Omnipodd is taking a condisderable amount of market share from Medtronic and Animas(especially Medtronic) The leaders of this company seem to know how to get things accomplished. They are smart and are working with several companies to integrate a closed loop system. Animas was bought out at $24.00. Omnipodd is far superior to Animas and will continue to take market share from both animas and medtronic. I expect a takeover sooner than later by J&J/ Abbott Labs. This Insulin pump is revolutionary and the two big pharma companies are competing as to who will acquire. If none of these players will acquire then Insulet will be sold to a pain management company or an investment firm. Happy selling!